E3A67B7B-7427-4C11-912B-166451072767
—
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- —
- overall_survival_months
- 14.388961892247043
- age_years
- 65
- sex
- Female
GSVA pathway preview (0 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
8 twins match this tumor's tissue · 2 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | 2C70D7BF-85C4-447B-B0F9-A129D6B49E77 | — | — | 0.951 |
| 2 | A85A0E3A-2CB9-40EB-80E9-125EC137151B | — | — | 0.948 |
| 3 | ERR2598102 | fetal | fetal | 0.941 |
| 4 | 10FB7E59-9D71-4AB9-8D06-9CFD2304D1BC | — | — | 0.937 |
| 5 | 332283CB-F855-4493-A259-7852FD37B9DC | — | — | 0.936 |
| 6 | 713B4DA5-FA8A-4E52-BACF-19B912467FBB | — | — | 0.933 |
| 7 | ERR2598229 | fetal | fetal | 0.932 |
| 8 | CB9E4206-E2F7-49EA-8FB2-E69E5BB3B018 | — | — | 0.928 |
| 9 | TCGA-22-5477-01A-01R-1635-07 | — | cohortSQ2 | 0.927 |
| 10 | 7DC6D598-8506-4680-81DF-C1D0F1B5C27D | — | — | 0.927 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 24 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| E2F_TARGETS | 0.677 | Inavolisib | — uncovered |
| G2M_CHECKPOINT | 0.646 | Inavolisib | — uncovered |
| MYC_TARGETS_V1 | 0.596 | Inavolisib | — uncovered |
| MYC_TARGETS_V2 | 0.552 | Idelalisib | — uncovered |
| MITOTIC_SPINDLE | 0.474 | Inavolisib | — uncovered |
| DNA_REPAIR | 0.464 | Idelalisib | — uncovered |
| PROTEIN_SECRETION | 0.352 | Remibrutinib | — uncovered |
| MTORC1_SIGNALING | 0.338 | Inavolisib | — uncovered |
| CHOLESTEROL_HOMEOSTASIS | 0.335 | Remibrutinib | — uncovered |
| OXIDATIVE_PHOSPHORYLATION | 0.321 | Remibrutinib | — uncovered |
| UNFOLDED_PROTEIN_RESPONSE | 0.308 | Idelalisib | — uncovered |
| WNT_BETA_CATENIN_SIGNALING | 0.289 | Inavolisib | — uncovered |
| HEDGEHOG_SIGNALING | 0.223 | Inavolisib | — uncovered |
| ANDROGEN_RESPONSE | 0.220 | Inavolisib | — uncovered |
| NOTCH_SIGNALING | 0.186 | Inavolisib | — uncovered |
| UV_RESPONSE_DN | 0.127 | Inavolisib | — uncovered |
| TGF_BETA_SIGNALING | 0.096 | Inavolisib | — uncovered |
| PEROXISOME | 0.095 | Idelalisib | — uncovered |
| PANCREAS_BETA_CELLS | 0.089 | Cobimetinib | — uncovered |
| UV_RESPONSE_UP | 0.063 | Idelalisib | — uncovered |